Article
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globally
2025-07-10
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Adaptive platform trials rapidly generate robust evidence, essential for resource-limited health systems like those in low- and middle-income countries (LMICs). We analyzed the return on investment (ROI) of an adaptive platform trial using Value of Implementation analysis. <bold>Methods:</bold> This was a retrospective observational cohort study comparing t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ecd18a27-5b86-5ce9-9eda-c5a2d97d3a02
- DOI
- 10.21203/rs.3.rs-6264788/v1
